Cargando…
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
Accurate detection of cytogenetic abnormalities has become more important for improving risk-adapted treatment strategies in multiple myeloma (MM). However, precise cytogenetic testing by fluorescence in situ hybridization (FISH) is challenged by the dilution effect of bone marrow specimens and poor...
Autores principales: | Ha, Jihye, Cho, Hyunsoo, Lee, Taek Gyu, Shin, Saeam, Chung, Haerim, Jang, Ji Eun, Kim, Soo-Jeong, Cheong, June-Won, Lee, Seung-Tae, Kim, Jin Seok, Choi, Jong Rak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117238/ https://www.ncbi.nlm.nih.gov/pubmed/35585097 http://dx.doi.org/10.1038/s41598-022-11676-w |
Ejemplares similares
-
Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma
por: Perumal, G, et al.
Publicado: (2014) -
Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
por: Hu, Ying, et al.
Publicado: (2016) -
Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification
por: Abdel-Qader, Hadeel Yaseen, et al.
Publicado: (2022) -
P800: CHARACTERIZATION OF REGULATORY T CELLS IN PATIENTS WITH MULTIPLE MYELOMA
por: Kim, Sojeong, et al.
Publicado: (2023) -
Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
por: Merz, Maximilian, et al.
Publicado: (2017)